0000950170-24-073042.txt : 20240613
0000950170-24-073042.hdr.sgml : 20240613
20240613162102
ACCESSION NUMBER: 0000950170-24-073042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240611
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nemirovsky Julian
CENTRAL INDEX KEY: 0001835535
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38436
FILM NUMBER: 241041506
MAIL ADDRESS:
STREET 1: 35 EAST 62ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SIGA TECHNOLOGIES INC
CENTRAL INDEX KEY: 0001010086
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 133864870
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 31 EAST 62ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10065
BUSINESS PHONE: 212-672-9100
MAIL ADDRESS:
STREET 1: 31 EAST 62ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10065
FORMER COMPANY:
FORMER CONFORMED NAME: SIGA PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19961108
4
1
ownership.xml
4
X0508
4
2024-06-11
false
0001010086
SIGA TECHNOLOGIES INC
SIGA
0001835535
Nemirovsky Julian
C/O SIGA TECHNOLOGIES, INC.
31 EAST 62ND STREET
NEW YORK
NY
10065
true
false
false
false
false
Common Stock, par value $.0001 per share
2024-06-11
4
M
false
24712
A
50928
D
Common Stock, par value $.0001 per share
2024-06-11
4
D
false
7414
7.86
D
43514
D
Restricted Stock Units
2024-06-11
4
M
false
24712
0
D
Common Stock, par value $.0001 per share
24712
0
D
Restricted Stock Units
2024-06-11
4
A
false
19084
0
A
Common Stock, par value $.0001 per share
19084
19084
D
Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.
Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 15, 2023. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs.
The RSUs were granted on June 13, 2023, and fully vested on the date of the Company's 2024 annual meeting of stockholders.
RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 5,725 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors.
The RSUs fully vest on the date of the Company's 2025 annual meeting of stockholders.
/s/ Kevin Buckley, as Attorney-in-Fact
2024-06-13